1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sleep-Wake Disorder Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Insomnia
1.2.3 Hypersomnia
1.2.4 Sleep Apnea
1.2.5 Circadian Rhythm Disorders
1.2.6 Others
1.3 Market by Treatment
1.3.1 Global Sleep-Wake Disorder Market Share by Treatment: 2017 VS 2021 VS 2028
1.3.2 Therapies
1.3.3 Medications
1.3.4 Devices
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Sleep-Wake Disorder Market Perspective (2017-2028)
2.2 Sleep-Wake Disorder Growth Trends by Region
2.2.1 Sleep-Wake Disorder Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Sleep-Wake Disorder Historic Market Size by Region (2017-2022)
2.2.3 Sleep-Wake Disorder Forecasted Market Size by Region (2023-2028)
2.3 Sleep-Wake Disorder Market Dynamics
2.3.1 Sleep-Wake Disorder Industry Trends
2.3.2 Sleep-Wake Disorder Market Drivers
2.3.3 Sleep-Wake Disorder Market Challenges
2.3.4 Sleep-Wake Disorder Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Sleep-Wake Disorder Players by Revenue
3.1.1 Global Top Sleep-Wake Disorder Players by Revenue (2017-2022)
3.1.2 Global Sleep-Wake Disorder Revenue Market Share by Players (2017-2022)
3.2 Global Sleep-Wake Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sleep-Wake Disorder Revenue
3.4 Global Sleep-Wake Disorder Market Concentration Ratio
3.4.1 Global Sleep-Wake Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sleep-Wake Disorder Revenue in 2021
3.5 Sleep-Wake Disorder Key Players Head office and Area Served
3.6 Key Players Sleep-Wake Disorder Product Solution and Service
3.7 Date of Enter into Sleep-Wake Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Sleep-Wake Disorder Breakdown Data by Type
4.1 Global Sleep-Wake Disorder Historic Market Size by Type (2017-2022)
4.2 Global Sleep-Wake Disorder Forecasted Market Size by Type (2023-2028) 5 Sleep-Wake Disorder Breakdown Data by Treatment
5.1 Global Sleep-Wake Disorder Historic Market Size by Treatment (2017-2022)
5.2 Global Sleep-Wake Disorder Forecasted Market Size by Treatment (2023-2028) 6 North America
6.1 North America Sleep-Wake Disorder Market Size (2017-2028)
6.2 North America Sleep-Wake Disorder Market Size by Country (2017-2022)
6.3 North America Sleep-Wake Disorder Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Sleep-Wake Disorder Market Size (2017-2028)
7.2 Europe Sleep-Wake Disorder Market Size by Country (2017-2022)
7.3 Europe Sleep-Wake Disorder Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Sleep-Wake Disorder Market Size (2017-2028)
8.2 Asia-Pacific Sleep-Wake Disorder Market Size by Country (2017-2022)
8.3 Asia-Pacific Sleep-Wake Disorder Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Sleep-Wake Disorder Market Size (2017-2028)
9.2 Latin America Sleep-Wake Disorder Market Size by Country (2017-2022)
9.3 Latin America Sleep-Wake Disorder Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Sleep-Wake Disorder Market Size (2017-2028)
10.2 Middle East & Africa Sleep-Wake Disorder Market Size by Country (2017-2022)
10.3 Middle East & Africa Sleep-Wake Disorder Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Detail
11.1.2 Jazz Pharmaceuticals Business Overview
11.1.3 Jazz Pharmaceuticals Sleep-Wake Disorder Introduction
11.1.4 Jazz Pharmaceuticals Revenue in Sleep-Wake Disorder Business (2017-2022)
11.1.5 Jazz Pharmaceuticals Recent Development
11.2 Koninklijke Philips N.V.
11.2.1 Koninklijke Philips N.V. Company Detail
11.2.2 Koninklijke Philips N.V. Business Overview
11.2.3 Koninklijke Philips N.V. Sleep-Wake Disorder Introduction
11.2.4 Koninklijke Philips N.V. Revenue in Sleep-Wake Disorder Business (2017-2022)
11.2.5 Koninklijke Philips N.V. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Sleep-Wake Disorder Introduction
11.3.4 Merck KGaA Revenue in Sleep-Wake Disorder Business (2017-2022)
11.3.5 Merck KGaA Recent Development
11.4 Neurocrine Biosciences
11.4.1 Neurocrine Biosciences Company Detail
11.4.2 Neurocrine Biosciences Business Overview
11.4.3 Neurocrine Biosciences Sleep-Wake Disorder Introduction
11.4.4 Neurocrine Biosciences Revenue in Sleep-Wake Disorder Business (2017-2022)
11.4.5 Neurocrine Biosciences Recent Development
11.5 RespireRx Pharmaceuticals Inc.
11.5.1 RespireRx Pharmaceuticals Inc. Company Detail
11.5.2 RespireRx Pharmaceuticals Inc. Business Overview
11.5.3 RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Introduction
11.5.4 RespireRx Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2017-2022)
11.5.5 RespireRx Pharmaceuticals Inc. Recent Development
11.6 Medtronic PLC
11.6.1 Medtronic PLC Company Detail
11.6.2 Medtronic PLC Business Overview
11.6.3 Medtronic PLC Sleep-Wake Disorder Introduction
11.6.4 Medtronic PLC Revenue in Sleep-Wake Disorder Business (2017-2022)
11.6.5 Medtronic PLC Recent Development
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Sleep-Wake Disorder Business (2017-2022)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.8 Vanda Pharmaceuticals Inc.
11.8.1 Vanda Pharmaceuticals Inc. Company Detail
11.8.2 Vanda Pharmaceuticals Inc. Business Overview
11.8.3 Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Introduction
11.8.4 Vanda Pharmaceuticals Inc. Revenue in Sleep-Wake Disorder Business (2017-2022)
11.8.5 Vanda Pharmaceuticals Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
